Articles that mention Novartis -BoardProspects

Novartis

0 Comments Leave a Comment

1-15 of 18 1 2 »
1. Mentioned In 18 Articles
2. Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.
  
  Explore The New York Times Aug 8 2019 BoardNews
  
  ...ponding to the agencys stern rebuke, Vas Narasimhan, the companys executive, tried to reassure investors that Novartis did not intentionally deceive the F.D.A. while seeking approval for its $2.1 million gene therapy ......
  Read Full Article
  
  Comment
  
  Mentions: Novartis Vas Narasimhan
3. Progenics to Mail Letter to Shareholders
  
  Explore Stock Market Data Today Jun 19 2019 BoardNews
  
  ...with significant experience in commercial-stage oncology products. For example, Michael Kishbauch established Novartis’ Oncology Field Force, helping to launch its first product, Aredia (pamidronate), and paving the way ...
  Read Full Article
  
  Comment
  
  Mentions: Corporate Governance Governance Committee Annual Meeting
4. UBiome's Independent Directors are Ditching the Healthcare Startup Following an FBI Raid
  
  Explore Business Insider May 15 2019 BoardNews
  
  ...Apte on administrative leave. John Rakow the company's general counsel, is serving as the interim CEO. Former Novartis CEO Joe Jimenez had been on UBiome's board as well, but resigned earlier in April prior to the FBI ra...
  Read Full Article
  
  Comment
  
  Mentions: Investors Independent Director Special Committee
5. Aspen Technology Appoints Georgia Keresty PhD, MPH to Its Board of Directors
  
  Explore businesswire.com Apr 18 2019 BoardMoves
  
  ...ovation. During a career that includes executive roles at Takeda, Johnson & Johnson, Bristol Myers Squibb and Novartis, Keresty has been responsible for operations in more than 20 countries and led a $150M R&D affiliate ...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Management Independent Director
6. AbbVie Investors Agitate for Chair-CEO Split, Flagging Bonus Pay and Humira Hikes
  
  Explore Pharma News Apr 2 2019 BoardNews
  
  ...er those patents hoping to launch its biosim, Cyltezo, before its rivals do. Top biosimilar makers, including Novartis' Sandoz unit and Mylan, have settled their own Humira patent fights with deals that put off launches ...
  Read Full Article
  
  Comment
  
  Mentions: Investors SEC Mylan
7. Novartis Faces Questions About Proxy Voting Independence
  
  Explore Front Page Mar 27 2019 BoardNews
  
  ...via GPS trackers and found that they were diverted and sent to Novartis headquarters instead. This means that Novartis can see the name of shareholders and their voting positions ahead of the shareholder meeting, indicat...
  Read Full Article
  
  Comment
  
  Mentions: proxy voting investigation independence
8. P&G to Buy German Merck’s Consumer Unit for $4.2 Billion
  
  Explore Bloomberg Apr 19 2018 BoardNews
  
  ... goods companies, they typically have far lower profit margins than the prescription pharmaceutical business. Novartis sold its interest in a consumer joint venture to partner GlaxoSmithKline Plc, gaining cash to invest ...
  Read Full Article
  
  Comment
  
  Mentions: Mylan Amazon JPMorgan
9. Ligand Appoints Dr. Nancy Gray to its Board of Directors
  
  Explore businesswire.com Aug 21 2017 BoardMoves
  
  ...iances, licenses and other business relationships with the world’s leading pharmaceutical companies including Novartis, Amgen, Merck, Pfizer, Celgene, Gilead, Janssen, Baxter International and Eli Lilly. Follow Ligand on...
  Read Full Article
  
  Comment
  
  Mentions: Twitter Amgen Pfizer
10. Surface Oncology Welcomes Industry Leader Daniel S. Lynch as Chairman of Board of Directors
  
  Explore businesswire.com Jan 4 2017 BoardMoves
  
  ... industry-leading syndicate of investors. In 2016, Surface entered into a global strategic collaboration with Novartis to bring four next-generation immunotherapies to patients. Sam Brown Inc. Cory Tromblee, 617-571-7220...
  Read Full Article
  
  Comment
  
  Mentions: Board Chair CEO Shareholders
11. Kura Oncology (KURA) Names Steven Stein to Board of Directors
  
  Explore StreetInsider.com Jan 3 2017 BoardMoves
  
  ...ation, where he most recently served as Senior Vice President, U.S. Clinical Development & Medical Affairs at Novartis Oncology U.S. Prior to Novartis, Dr. Stein worked at GlaxoSmithKline as Vice President, Global Oncolo...
  Read Full Article
  
  Comment
  
  Mentions: Board Recruitment Shareholders Novartis
12. Are Massive Severance Packages to Fired CEOs Justified?
  
  Explore Scroll.in Dec 19 2016 BoardBlogs
  
  ... Even severance packages of successful CEOs are hard for the public to swallow. For example, Danny Vasella of Novartis was to be paid 72 million Swiss Francs over six years, provided he did not go to work for the competi...
  Read Full Article
  
  Comment
  
  Mentions: Executive Compensation Google stock options
13. Warp Drive Bio Appoints Rachel K. King to Its Board of Directors
  
  Explore cbs8.com Jul 5 2016 BoardMoves
  
  ...usly, she held positions of increasing responsibility with Genetic Therapy Inc., a wholly-owned subsidiary of Novartis, including as the company’s chief executive officer. Earlier in her career, she worked for the ALZA C...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Sanofi Shareholders
14. Nordic Nanovector Brings on New Board Member
  
  Explore businesswire.com May 23 2016 BoardNews
  
  ...sive life sciences consulting and advisory experience as well as leadership experience from companies such as Novartis, Bristol Myers Squibb and Merck. She holds a Bachelor of Science degree in Pharmacy from the Universi...
  Read Full Article
  
  Comment
  
  Mentions: Canada Merck Shareholders
15. BIO's Jim Greenwood will Chair BVGH's Board of Directors.
  
  Explore news.thomasnet.com Mar 23 2016 BoardMoves
  
  ...laborations in 2012 to 96 collaborations by end of 2015. Takeda and Johnson & Johnson recently joined Pfizer, Novartis, GSK, Merck (MSD), Sanofi, Alnylam, Eisai, and Merck KGaA in contributing their resources to advance ...
  Read Full Article
  
  Comment
  
  Mentions: Board Chair Annual Meeting Sanofi
16. Proteus Digital Health Announces New Chairman of the Board and Chief Commercial Officer
  
  Explore Yahoo! Finance Nov 17 2015 BoardMoves
  
  ...y, Calif., Proteus is privately held and funded by leading institutional and corporate investors, including:, Novartis, Otsuka, Oracle and Kaiser Permanente. For more information, visit www.proteus.com. Copyright © 2015 ...
  Read Full Article
  
  Comment
  
  Mentions: Oracle Europe India
17. 1-15 of 18 1 2 »